Club细胞蛋白CC10减轻烟雾吸入诱导的急性呼吸窘迫综合征
本研究为随机、对照、前瞻性大动物转化研究,在36只成年雌性绵羊烟雾吸入损伤(SII)模型中评估重组人Club细胞10-kDa蛋白(rhCC10)的剂量效应。除假手术组外,各组均经冷却棉烟吸入制模后接受机械通气,分别静脉给予1、3、10 mg/kg/d rhCC10或溶媒,每日分两次每12小时给药,并液体复苏、清醒状态监测48小时。结果显示10 mg/kg/d rhCC10组可减轻PaO2/FiO2比值、氧合指数和峰值吸气压力的变化,降低气道中性粒细胞含量和髓过氧化物酶水平,减轻大小气道阻塞、全身液体和蛋白漏出及肺水肿。作者认为高剂量rhCC10可能作为SII诱导ARDS的新型治疗选择。
要点
- 在烟雾吸入致ARDS绵羊模型中,10 mg/kg/d rhCC10组减轻PaO2/FiO2比值、氧合指数和峰值吸气压力的变化。
- 10 mg/kg/d rhCC10降低气道中性粒细胞含量和髓过氧化物酶水平,并减轻大小气道阻塞。
- 10 mg/kg/d rhCC10减少全身液体和蛋白漏出及肺水肿,使液体平衡正常化。
- rhCC10每日分两次每12小时静脉给药,剂量分别为1、3、10 mg/kg/d,监测48小时。
- 作者认为rhCC10可能作为SII诱导ARDS的新型治疗选择。
适用人群与场景
- 成年雌性绵羊烟雾吸入损伤(SII)模型,经冷却棉烟吸入制模后机械通气、液体复苏并清醒监测48小时。
- 假手术组(无SII)n=6;1 mg/kg/d CC10组n=8;3 mg/kg/d CC10组n=7;10 mg/kg/d CC10组n=8;SII对照组n=7。
处置流程与药物剂量
- 除假手术组外,所有组经冷却棉烟吸入诱导SII,随后置于呼吸机通气并液体复苏。
- rhCC10静脉给药,剂量分别为1、3、10 mg/kg/d,每日分两次每12小时给药一次,监测48小时。
研究设计与关键结果
- 研究类型为随机、对照、前瞻性大动物转化研究,共36只成年雌性绵羊,在大学大动物ICU进行。
- 10 mg/kg/d rhCC10组减轻PaO2/FiO2比值、氧合指数和峰值吸气压力的变化。
- 10 mg/kg/d rhCC10组降低气道中性粒细胞含量和髓过氧化物酶水平,减轻大小气道阻塞。
- 10 mg/kg/d rhCC10组减少全身液体和蛋白漏出及肺水肿,使液体平衡正常化。
- 作者结论认为高剂量rhCC10显著减轻ARDS进展和肺功能障碍,显著减少全身液体和蛋白外渗、使液体平衡正常化。
证据类型、等级与局限
- 证据类型:随机、对照、前瞻性大动物转化研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为基于上述结果,rhCC10可考虑作为SII诱导ARDS的新型治疗选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the dose effects of Recombinant human Club cell 10-kDa protein (rhCC10) on lung function in a well-characterized ovine model of acute respiratory distress syndrome (ARDS) induced by smoke inhalation injury (SII); specifically, the potential of rhCC10 protein to control the inflammatory response and protect pulmonary tissue and function following SII.
DESIGN: Randomized, controlled, prospective, and large animal translational studies.
SETTING: University large animal intensive care unit.
SUBJECTS: Thirty-six adult female sheep were surgically prepared and allocated into five groups (Sham (no SII), n = 6; 1 mg/kg/d CC10, n = 8; 3 mg/kg/d CC10, n = 7; 10 mg/kg/d CC10, n = 8; Control SII, n = 7).
INTERVENTIONS: All groups except the sham group were subjected to SII with cooled cotton smoke. Then, the animals were placed on a ventilator, treated with 1, 3, and 10 mg/kg/d of intravenous rhCC10 or vehicle, divided evenly into two administrations per day every 12 h, fluid resuscitated, and monitored for 48 h in a conscious state.
MEASUREMENTS AND MAIN RESULTS: The group treated with 10 mg/kg/d rhCC10 attenuated changes in the following variables: PaO2/FiO2 ratio, oxygenation index, and peak inspiratory pressure; neutrophil content in the airway and myeloperoxidase levels; obstruction of the large and small airways; systemic leakage of fluid and proteins, and pulmonary edema.
CONCLUSIONS: In this study, high-dose rhCC10 significantly attenuated ARDS progression and lung dysfunction and significantly reduced systemic extravasation of fluid and proteins, normalizing fluid balance. Based on these results, rhCC10 may be considered a novel therapeutic option for the treatment of SII-induced ARDS.
参考来源
- Lopez E, Fujiwara O, Nelson C, et al. Club Cell Protein, CC10, Attenuates Acute Respiratory Distress Syndrome Induced by Smoke Inhalation. Shock. 2020. PMID: 31045988. doi:10.1097/SHK.0000000000001365
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。